NSE - Delayed Quote INR

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

Compare
1,004.00
-6.50
(-0.64%)
At close: January 10 at 3:30:01 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
292,808,000.00
257,564,000.00
277,954,000.00
238,847,000.00
Total Liabilities Net Minority Interest
71,792,000.00
60,681,000.00
87,416,000.00
89,551,000.00
Total Equity Gross Minority Interest
221,016,000.00
196,883,000.00
190,538,000.00
149,296,000.00
Total Capitalization
198,295,000.00
175,158,000.00
173,617,000.00
136,018,000.00
Common Stock Equity
198,295,000.00
175,158,000.00
169,996,000.00
129,923,000.00
Capital Lease Obligations
356,000.00
317,000.00
249,000.00
241,000.00
Net Tangible Assets
119,525,000.00
116,209,000.00
105,078,000.00
64,095,000.00
Working Capital
61,595,000.00
44,857,000.00
44,220,000.00
8,547,000.00
Invested Capital
205,981,000.00
186,790,000.00
211,956,000.00
175,758,000.00
Tangible Book Value
119,525,000.00
116,209,000.00
105,078,000.00
64,095,000.00
Total Debt
8,042,000.00
11,949,000.00
42,209,000.00
46,076,000.00
Net Debt
3,556,000.00
6,754,000.00
35,382,000.00
39,183,000.00
Share Issued
1,006,233.99
1,012,204.14
1,023,742.60
1,023,742.60
Ordinary Shares Number
1,006,233.99
1,012,204.14
1,023,742.60
1,023,742.60
3/31/2021 - 4/27/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers